Christopher Glynn’s practice focuses on patent prosecution and strategic portfolio development, client counseling, and opinion work. Dr. Glynn’s practice also focuses on patent disputes, including patent reexaminations, interferences and inter partes reviews.
Dr. Glynn has prepared and prosecuted patent applications; prepared validity, infringement and freedom-to-operate opinions; and handled due diligence reviews in the context of intellectual property sales and acquisitions. This work has been in the areas of chemistry and organic synthesis, polymer chemistry, pharmaceuticals including small molecules and drug delivery systems, material science and biotechnology.
Dr. Glynn has experience in patent litigations involving pharmaceutical products, dietary supplements, chemical processes, and DNA diagnostics. He also has experience with ANDA patent litigation under the Hatch-Waxman Act.
Dr. Glynn’s doctoral research involved the multi-step synthesis of novel organic ligands and organo-metallic coordination polymers.